Article - Issue 02
Rare Diseases Medicine: Advantages, Challenges, and Future Developments
Article - Issue 03
Pooling: An Untapped Clinical Supply Chain Strategy
Article - Issue 03
NextPoint Therapeutics a biotechnology company in the clinical stage has disclosed the acceptance of its investigational new drug application by the US Food Drug Administration
Vittoria Biotherapeutics has achieved a significant milestone with the clearance of its Investigational New Drug application by the US Food and Drug Administration This clearance paves the way for the initiation
Velocity Clinical Research a renowned organization specializing in clinical research across diverse medical fields has announced its expansion into Poland through the acquisition of its inaugural center ClinMedica Research
Philogen SpA is thrilled to announce that its new GMP facility in Rosia Siena has received GMP certification The Agenzia Italiana del Farmaco
Rumi Scientific a company focused on developing therapies for rare and neurodegenerative diseases using its high throughput organoid phenotypic screening platform has announced a collaboration with XChem
Acino a Swiss pharmaceutical company based in Zurich has recently finalized the acquisition of M Pharmaceuticals a rapidly growing specialty biopharmaceutical firm headquartered in Mexico City M focuses on licensing
Basilea Pharmaceutica Ltd Allschwil a commercialstage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections announced today that its license partner Astellas Pharma US Inc
Kura Oncology Inc a clinicalstage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer and The Leukemia Lymphoma Society
.jpg){kind=logo}
EFFECTOR Therapeutics Inc a leader in the development of selective translation regulator inhibitors for the treatment of cancer today announced new positive interim data from dose escalation
Ipsen and GENFIT today announced that the US Food and Drug Administration has accepted the New Drug Application for investigational elafibranor
Dubai, UAE
London, UK
Amsterdam, Netherlands
London, UK
Berlin, Germany
Freeport, Bahamas
Columbus, USA
Distinguished Professor Emeritus, University of California
Biochemistry & Bioinformatics Laboratory, Department of Applied Sciences, Indian Institute of Information Technology Allahabad.
Biochemistry & Bioinformatics Laboratory, Department of Applied Sciences, Indian Institute of Information Technology Allahabad
Persistent Systems Ltd
R&D Scientist, Leiden University
Adex Pharmaceutical Consultancy Services (OPC) Pvt. Ltd.
Department of Pharmaceutics, R. C. Patel Institute of Pharmaceutical Education and Research
Department of Pharmaceutics, R. C. Patel Institute of Pharmaceutical Education and Research
The European pharmaceutical landscape has undergone remarkable transformations in recent years with the emergence of biosimilars playing a pivotal role in reshaping the industry Before delving into the intricacies of biosimilars
Paracelsus in the th century established the principle of toxicology that the dose of a medicinal defines the difference between a remedy and a toxic effect
As pathogens continue to evolve and resistance strategies become more sophisticated new solutions are very crucial
In EU the middleclass in Pharma is disappearing companies with revenues by M with a small factory and operations limited to some few countries
Cannabis plants contain a wide variety of complex compounds including phytocannabinoids terpenoids and flavonoids found mainly in the inflorescences Major phytocannabinoids like CBD and THC have beneficial effects on human health
To enable the effective preclinical testing efficacy and safety evaluation followed by firstinman studies formulation scientists must come up with effective strategies to achieve the desired bioavailability of these poorly soluble compounds
The enzyme thioredoxin reductase TrxR known for its antioxidative properties has been proposed as a potential drug target for various pathogens including the protist parasite Giardia lamblia
Mounjaro tirzepatide injection developed by Eli Lilly and Company is a novel dualtargeted therapy that has been demonstrated to enhance glycemic control in adult patients with type diabetes In people with type diabetes a onceweekly glucosedependent insulinotropic polypeptide GIP and glucagonlike peptide
In the everevolving landscape of the European pharmaceutical industry this article offers a comprehensive analysis of the strategic initiatives shaping the sector From navigating regulatory complexities to exploring market trends
The challenges associated with rare diseases are numerous and multifaceted
The bloodtoplasma ratio BP ratio or Rb is an important parameter in pharmacokinetics PK that reflects the distribution of a drug between red blood cells RBCs and plasma
The biopharmaceutical industry is a highly regulated and complex industry where the timely and safe delivery of lifesaving treatments to patients is of utmost importance
In the everevolving realm of pharmaceutical research and development RD the powerful wave of digitalization is restructuring conventional methodologies and paving the way for a novel era of ingenuity and streamlined processes
With our SOP process we can assure to have a balanced liquidity and stock material that corresponds to customers demand
.jpg "Juris Hmelnickis")
